Marialuisa Longo | Orthodontics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Marialuisa Longo | Orthodontics | Best Researcher Award

University of Bari “Aldo Moro” | Italy

Dr. Marialuisa Longo is a dedicated academic and researcher at the University of Bari “Aldo Moro,” specializing in orthodontics and dentistry. Her work integrates both clinical expertise and research-driven innovation, with a strong commitment to enhancing patient care through advanced methodologies and digital tools. Through her contributions, she has helped bridge the gap between traditional orthodontic practices and modern technological approaches. Her scholarly output includes several peer-reviewed journal publications that highlight her impact on improving treatment effectiveness and patient experience. She is an active member of professional organizations such as SIDO, SUSO, and AIDOR, which reflects her commitment to professional development and collaborative knowledge exchange. Dr. Longo’s research and academic endeavors exemplify a balance between theory and practice, making her contributions valuable to both scientific advancement and clinical applications. With a clear vision of advancing dental sciences, she continues to inspire innovation and quality care in orthodontics.

Profile

ORCID

Education

Dr. Marialuisa Longo pursued her academic journey at the University of Bari “Aldo Moro,” where she developed her expertise in dentistry and orthodontics. Her education was marked by rigorous training in both theoretical knowledge and practical applications, equipping her with the skills necessary to excel in academic and clinical practice. The curriculum emphasized an interdisciplinary approach, fostering her understanding of advanced orthodontic methodologies, patient-centered care, and integration of emerging technologies into dental practice. Throughout her education, Dr. Longo was actively involved in research-oriented learning, which laid the foundation for her later scholarly contributions. She demonstrated a strong aptitude for critical thinking, clinical problem-solving, and innovation in dental sciences. Her academic preparation provided her with a comprehensive understanding of the complexities of oral health and orthodontics, shaping her career as both a practitioner and a researcher. The combination of scientific rigor and clinical immersion during her education defines her academic excellence.

Experience

Dr. Marialuisa Longo has cultivated her professional experience at the University of Bari “Aldo Moro,” where she combines academic research, teaching, and clinical practice in dentistry and orthodontics. Her professional journey reflects a dedication to advancing orthodontic treatment through innovative techniques and interdisciplinary collaborations. She has authored several peer-reviewed journal articles that demonstrate her ability to translate scientific knowledge into practical solutions. Her work emphasizes enhancing treatment effectiveness, patient comfort, and the integration of digital tools into modern orthodontic practice. Through her memberships in professional organizations such as SIDO, SUSO, and AIDOR, Dr. Longo engages with the wider dental community, ensuring her work remains informed by global standards and contemporary developments. Her experience is also characterized by mentoring and contributing to the academic development of students, fostering the next generation of dental professionals. The combination of clinical, research, and academic experience makes her a versatile and impactful contributor to dentistry.

Awards and Honors

Dr. Marialuisa Longo’s academic and professional achievements reflect recognition of her contributions to the field of dentistry and orthodontics. Her published research in peer-reviewed journals showcases her commitment to advancing knowledge and improving clinical practice, earning respect within the scientific community. As an active member of prestigious professional associations such as SIDO, SUSO, and AIDOR, she has gained acknowledgment for her engagement in collaborative research and clinical excellence. While her career is still evolving, the quality and significance of her work demonstrate award-worthy accomplishments in integrating innovative technologies with orthodontic care. Her recognition extends beyond publications to her role as a contributor to the academic and clinical missions of the University of Bari “Aldo Moro.” Her ongoing commitment to excellence, coupled with her dedication to patient-focused research and practice, positions her as a promising and deserving candidate for professional honors and awards within the dental sciences.

Research Focus

Dr. Marialuisa Longo’s research focuses on orthodontics and the development of innovative strategies that improve patient care and clinical efficiency. She is particularly interested in integrating digital tools and advanced technologies into traditional orthodontic practices, making treatments more precise, effective, and comfortable for patients. Her published works highlight her contributions to bridging the gap between clinical methodologies and scientific research, ensuring that innovation is directly applied in real-world practice. By collaborating across disciplines within the University of Bari “Aldo Moro,” she contributes to the adoption of evidence-based techniques that transform orthodontic outcomes. Her focus also extends to improving patient experience, emphasizing comfort and efficiency in treatment protocols. Through active involvement in professional associations, she continually aligns her research with the evolving standards of global dentistry. Dr. Longo’s research represents a blend of academic rigor and clinical practicality, aimed at advancing orthodontics through innovation and patient-centered approaches.

Conclusion

Dr. Marialuisa Longo exemplifies the spirit of innovation and dedication in orthodontics through her research, clinical practice, and academic contributions at the University of Bari “Aldo Moro,” where she continuously strives to integrate modern technologies, enhance patient care, and contribute to the global advancement of dentistry, making her an outstanding candidate for the Best Researcher Award.

Muhammad Saeed | Clinical Research | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Saeed | Clinical Research | Best Researcher Award

PRX Research | United States

Dr. Muhammad  Saeed is a highly accomplished physician and clinical research leader with extensive expertise in advancing medical innovation. He has dedicated his career to bridging clinical practice and research, focusing on infectious diseases, chronic illnesses, and novel therapeutics. With a foundation in medicine from Dow Medical College, he progressed to leadership positions in multiple U.S.-based clinical research centers, where he directed diverse clinical trials across infectious diseases, neurology, oncology, cardiology, and respiratory medicine. His contributions extend to both academia and industry, including collaborative work with prestigious global institutions. Dr. Saeed’s scholarly work encompasses book chapters and peer-reviewed publications that highlight his dedication to evidence-based medicine and medical education. Beyond his scientific contributions, he is recognized for mentoring young professionals and promoting ethical research practices. His blend of clinical acumen, research excellence, and leadership has positioned him as a key figure in modern translational research and therapeutic development.

Profile

ORCID

Education

Dr. Muhammad Saeed’s academic journey reflects a commitment to excellence and lifelong learning. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow Medical College, University of Karachi, laying the groundwork for his career in clinical medicine and research. His early training emphasized core competencies in surgery and internal medicine, which provided him with strong clinical insights that continue to inform his research leadership. He later pursued advanced studies at Johns Hopkins University, where he completed a Master of Science, equipping him with rigorous training in epidemiology, clinical trial design, and evidence-based research methodologies. His education also includes formative years at Habib Public School in Karachi, where he achieved GCE O’ Levels under the University of Cambridge Local Examination Syndicate. This broad educational foundation, spanning global institutions of repute, has allowed him to integrate strong clinical skills with research innovation, shaping his role as a physician-scientist and educator.

Experience

Dr. Muhammad Saeed’s professional experience spans diverse roles in clinical medicine and research. He began his medical career as a resident physician at Civil Hospital Karachi, training in surgery and medicine. His early exposure to hospital-based care was complemented by research responsibilities at Aga Khan University Hospital, where he worked as a Clinical Research Associate on infectious diseases and public health projects. Transitioning to the United States, he held leadership positions at Advanced Clinical Research Associates in Plano, HRMD Research in Dallas, and later Dallas Regional Medical Center and PRX Research in Mesquite, where he currently serves as Clinical Research Director. In these roles, he has overseen numerous multicenter, international clinical trials across therapeutic areas including oncology, neurology, cardiology, infectious diseases, and COVID-19. His leadership ensures regulatory compliance, patient safety, and high-quality outcomes in research. This experience highlights his ability to integrate patient care, research innovation, and administrative excellence.

Awards and Honors

Dr. Muhammad Saeed has been recognized for his outstanding contributions to clinical research, academic medicine, and patient-centered healthcare. His work in infectious disease research and clinical trial leadership has earned him respect among peers in both academic and industry settings. He has collaborated with leading researchers globally, resulting in publications and recognition in international medical circles. His co-authored book, What I Wish I Knew Before Medical School, reflects his dedication to mentoring and educating the next generation of healthcare professionals, further enhancing his academic reputation. His chapter contributions to the International Encyclopedia of Public Health positioned him among notable voices in global health. Over his career, he has been acknowledged for his role in advancing therapeutic development, particularly during the COVID-19 pandemic through multiple high-impact trials. These honors reflect not only his scholarly achievements but also his contributions to improving medical care through innovative and ethical clinical research practices

Research Focus

Dr. Muhammad Saeed’s research focus lies at the intersection of clinical innovation and public health. His academic research has addressed infectious diseases, including typhoid detection in children and diabetes risk factors in underserved communities. In industry, he has spearheaded large-scale multicenter clinical trials across diverse therapeutic areas, including cardiology, oncology, neurology, respiratory diseases, and COVID-19. His work emphasizes patient safety, treatment efficacy, and advancing therapeutic options for conditions with high unmet medical needs. He has been deeply involved in clinical trial design, implementation, and analysis, ensuring robust outcomes that translate into better clinical practices. Beyond therapeutic innovation, Dr. Saeed’s work reflects a commitment to advancing methodologies for early disease detection, novel biomarkers, stem-cell based therapies, and cutting-edge treatments for neurodegenerative and chronic illnesses. His research philosophy integrates medical rigor, ethical practice, and translational application, aiming to bring scientific discovery from the research bench directly to patient care with lasting global impact.

 

Publications

Title: Impacts of Ambient Temperatures on Pediatric Anemia in Sub-Saharan Africa: A Regional Ecological Study
Year: 2025

Title: Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis
Year: 2022

Title: Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
Year: 2022

Title: Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Year: 2020

Title: Clinical characteristics, management and outcome of major pulmonary embolism: an experience from a tertiary care center in Pakistan
Year: 2009

Conclusion

Dr. Muhammad  Saeed is a distinguished physician-scientist whose career blends clinical expertise, research leadership, and academic scholarship, with a strong focus on advancing therapeutic innovation, improving patient care, and mentoring future medical professionals through global collaborations and ethical research excellence.

Gang Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Gang Liu | Medicine and Health Sciences| Best Researcher Award

The Affiliated Hospital of Guizhou Medical University | China

Gang Liu, M.D., is a highly regarded Professor and Chief Physician of Orthopaedics at the Department of Emergency Orthopedics, The Affiliated Hospital of Guizhou Medical University. Serving also as a Master’s Supervisor, Dr. Liu has made substantial contributions to orthopaedic trauma care, with a clinical and academic career rooted in improving outcomes for patients with complex fractures and injuries. Known for his precision in surgical techniques and commitment to academic mentoring, he leads innovative research in trauma surgery and biomechanics. His leadership in the department reflects his dedication to clinical excellence, education, and advancing orthopaedic science. As an influential voice in orthopaedic medicine in China, Dr. Liu combines decades of hands-on experience with a forward-looking approach to research and treatment, helping shape the next generation of specialists in trauma care. His work bridges the gap between clinical application and academic research, fostering advancements in evidence-based orthopaedic medicine.

Profile

ORCID

Education

While specific educational details about Dr. Gang Liu are not publicly listed, his current academic and professional status indicates extensive medical training, including the attainment of a Doctor of Medicine (M.D.) degree, likely followed by specialized residency and fellowship programs in orthopaedic surgery. As a Professor and Chief Physician, he has undoubtedly completed postgraduate and professional training in trauma and emergency orthopaedics, biomechanics, and surgical innovation. His role as a Master’s Supervisor suggests strong academic foundations and consistent engagement with scholarly research. Dr. Liu is affiliated with Guizhou Medical University, where he likely received or has contributed significantly to medical education. His educational trajectory exemplifies the rigorous academic and clinical preparation typical of senior physician-scientists in China’s leading medical institutions. His expertise reflects years of advanced learning in both clinical practice and orthopaedic science, enabling him to train the next generation of surgeons and researchers with a firm grounding in trauma and biomechanics.

Experience

Dr. Gang Liu currently serves at the Affiliated Hospital of Guizhou Medical University in Guiyang, China, where he is a Professor, Chief Physician in Orthopaedics, and a Master’s Supervisor. With decades of clinical and teaching experience, he plays a pivotal role in emergency orthopaedics, specializing in trauma management and fracture treatment. His leadership in the Department of Emergency Orthopedics involves not only patient care but also surgical innovation and departmental development. Dr. Liu has extensive experience in applying biomechanics to orthopaedic practice, aligning clinical strategies with research-based methodologies. His commitment to teaching and mentoring graduate students positions him as a key academic figure within the university. He integrates research, clinical service, and academic mentorship, demonstrating a rare balance of practical and theoretical knowledge in orthopaedics. His experience reflects the depth of his involvement in complex surgical procedures, clinical trials, and strategic planning for orthopaedic care in academic hospital settings.

Awards and Honors

Although detailed information on Dr. Gang Liu’s specific awards and honors is not publicly disclosed, his distinguished titles—Professor, Chief Physician, and Master’s Supervisor—indicate recognition for excellence in clinical practice, education, and research. Such positions in China’s medical hierarchy are awarded based on years of exceptional service, academic contributions, and leadership in healthcare delivery. It is likely that Dr. Liu has received institutional commendations and possibly regional or national recognition for his work in trauma and fracture care. His role in mentoring postgraduates suggests academic honors or commendations for teaching and research guidance. His contributions to biomechanics research and emergency orthopaedics may have earned him research grants or hospital-level awards for innovation or service excellence. As a senior figure at the Affiliated Hospital of Guizhou Medical University, he exemplifies the attributes of a respected physician-scientist whose reputation is built on both clinical outcomes and contributions to the academic and research mission of the institution.

Research Focus

Dr. Gang Liu’s research focuses on trauma, fracture management, and biomechanics in orthopaedic medicine. His work aims to improve understanding of the mechanical and biological responses of bone and soft tissue to injury, optimizing both surgical techniques and recovery outcomes. He explores how trauma impacts musculoskeletal function and how biomechanics can inform fracture fixation and healing strategies. At the Department of Emergency Orthopedics, Dr. Liu integrates research into clinical practice, conducting translational studies that advance evidence-based protocols in trauma care. His investigations likely include experimental and clinical trials, examining both traditional and modern surgical interventions. Emphasizing interdisciplinary collaboration, his research contributes to innovations in implant design, bone regeneration, and trauma surgery protocols. As a Master’s Supervisor, he mentors students on research methodologies, encouraging rigorous scientific exploration in orthopaedics. Dr. Liu’s research strengthens the link between clinical need and scientific discovery in the rapidly evolving field of emergency orthopaedic care.

Conclusion

Dr. Gang Liu stands as a dedicated leader in orthopaedic trauma care, combining clinical expertise, academic mentorship, and biomechanical research to improve patient outcomes and train future surgeons.

Muhammad Zia | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Zia | Pharmacology | Best Researcher Award

College of staten island | United States

Dr. Muhammad K. Zia is a medical professional and educator specializing in biological and medical sciences, currently serving as a Doctoral Lecturer in the Department of Biology at the College of Staten Island/CUNY. With an M.B.B.S. from Jinnah Sindh Medical University, Dr. Zia brings over two decades of diverse experience spanning clinical practice, higher education, and scientific research. He has contributed significantly to undergraduate science education through positions at Kean University, Fairleigh Dickinson University, and other academic institutions. His clinical background includes roles in pathology and diabetology in both the U.S. and Pakistan. Notably, he was awarded the PSC-CUNY research grant to study the effects of angiotensin receptor blockers on diabetic nephropathy. A dedicated mentor and presenter, Dr. Zia has supervised multiple student research posters and actively contributes to academic development at CSI. His interdisciplinary expertise uniquely bridges clinical knowledge with life science education and research.

Profile

ORCID

Education

Dr. Muhammad K. Zia earned his medical degree (M.B.B.S.) from Jinnah Sindh Medical University in Karachi, Pakistan. His training equipped him with a solid foundation in clinical medicine, including internal medicine, diagnostics, pathology, and patient care. Following graduation, he pursued additional clinical training and gained certification to practice medicine in Pakistan. Over time, he transitioned into academic medicine, combining his clinical expertise with pedagogy in biological sciences. He has complemented his education with ongoing professional development and has contributed to academic settings through student mentorship, course delivery, and research guidance. His deep understanding of clinical biology, pathology, and pharmacological interventions forms the basis of his teaching philosophy. While he holds no formal advanced academic degrees beyond his medical license, Dr. Zia has consistently demonstrated a commitment to educational excellence and medical scholarship, as evidenced by his active teaching roles and scholarly contributions in academic institutions in both the U.S. and abroad.

Experience

Dr. Zia’s professional journey reflects a balanced blend of academic instruction and clinical medicine. He has served as a Doctoral Lecturer at the College of Staten Island, following 12 years as an adjunct and substitute instructor. His teaching experience also spans Kean University, Union County College, Stevens Institute of Technology, and Wagner College, where he taught various biology and medical science courses. In the clinical domain, Dr. Zia has worked as a Medical Assistant in New Jersey, a Pathology Assistant at QDx Pathology Services, and held roles such as Associate Diabetologist and Resident Medical Officer at Baqai Medical University. Earlier in his career, he served as a Clinical Assistant at Imam Clinic in Karachi. His clinical responsibilities included diagnostics, treatment planning, minor procedures, and patient education. This extensive experience across multiple institutions showcases his ability to deliver science education enriched by real-world medical practice.

Awards and Honors

Dr. Muhammad K. Zia has been recognized for his commitment to academic research and mentorship through the PSC-CUNY Cycle 54 Research Grant. The award supported his study on the effects of Angiotensin Receptor Blockers in diabetic nephropathy, showcasing his initiative in clinical and retrospective research. His efforts to promote scientific inquiry among undergraduates were further highlighted through his supervision of multiple poster presentations at the CSI Undergraduate Conference on Research, Scholarship, and Arts. These included literature reviews on SGLT2 inhibitors, Parkinson’s disease interventions, and cardiovascular risks linked to supraventricular tachycardia. Dr. Zia has also presented workshops such as “How to Write a Reference Letter to Support Pre-Med Students,” contributing to the academic development of aspiring physicians. While he may not yet have amassed a wide array of traditional academic honors, his consistent involvement in student mentorship, curriculum enrichment, and funded research speaks volumes about his dedication and impact.

Research Focus

Dr. Zia’s research interests center on the intersection of clinical medicine and chronic disease management. His primary focus includes diabetic complications, particularly diabetic nephropathy and the therapeutic role of angiotensin receptor blockers. He is also interested in cardiovascular pharmacology and endocrinology, as demonstrated by his guidance of student research on SGLT2 inhibitors and their cardioprotective effects. His approach often involves retrospective chart reviews and critical literature analysis using credible medical databases like PubMed and the European Journal of Medicine. He further engages in collaborative educational research and academic mentoring, particularly within undergraduate settings. Dr. Zia’s supervised projects span diverse clinical areas, such as Parkinson’s disease interventions and arrhythmia outcomes, reflecting his broad scientific curiosity and integrative knowledge of pathophysiology. Through these initiatives, he fosters critical thinking and evidence-based research skills among students, contributing to a stronger foundation in translational medicine and interdisciplinary health sciences education.

Publications

Title: Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study
Year: 2025

Conclusion

Dr. Muhammad K. Zia’s multidimensional career—rooted in clinical medicine and expanded through academic instruction and student mentorship—demonstrates a sustained commitment to bridging medical science with impactful education and applied research.

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675

 

 

Nathan Robert Wall | Medicine | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Nathan Robert Wall | Medicine | Excellence in Research Award

Dr. Nathan R. Wall is an accomplished academic, biomedical researcher, and military officer. He is currently an Associate Professor of Medicine at Loma Linda University School of Medicine and holds multiple leadership roles in research, oncology education, and national defense. With advanced degrees in biology, cancer biology, and business administration, he has dedicated his career to cancer research and military medical operations. Dr. Wall has served in multiple deployments with the California Army National Guard, including missions in Afghanistan, Poland, and Iraq. His military and academic excellence is recognized through numerous awards and honors. Dr. Wall combines rigorous research in molecular medicine with a passion for leadership, education, and national service. His extensive experience in academia, clinical research, and military command uniquely positions him at the intersection of science and strategic operations, contributing to both medical advancement and national security.

Profile

Education 🎓

Dr. Nathan R. Wall is currently pursuing a Master of Strategic Studies at the U.S. Army War College (2024–2026). He earned his MBA with a focus in Management from the University of Redlands (2006–2008), and a Ph.D. in Cancer Biology from Wayne State University (1996–2000), where he also completed an M.S. in Molecular Biology and Genetics. Prior to that, he obtained an M.S. in Biology (1992–1995) and a B.S. in Biology with a minor in Chemistry (1987–1991) from Walla Walla College (now Walla Walla University). His graduate training included mentorship under leading scientists like Dr. Ayad M. Al-Katib and Dr. Joan M. Redd. Across disciplines—from molecular biology to strategic leadership—Dr. Wall’s education reflects a commitment to interdisciplinary excellence, equipping him with the skills to navigate both biomedical research and complex military operations with strategic insight.

Experience 👨‍🏫

Dr. Nathan R. Wall has held academic appointments at Loma Linda University since 2008, currently serving as Associate Professor of Medicine in the Division of Human Anatomy. He also directs Research and Development at the James M. Slater Proton Treatment & Research Center and is Oncology Thread Director at the School of Medicine. Previously, he served in the Department of Biochemistry and Center for Health Disparities. Since 2008, Dr. Wall has simultaneously served in the California Army National Guard, rising through the ranks and completing deployments to Afghanistan, Poland, and Iraq in key command roles. He has also contributed as a scientific advisor for biotech firms and participated in Department of Defense medical research review panels. His interdisciplinary experience spans military medicine, molecular oncology, academic leadership, and national defense, making him a unique leader who bridges science, strategy, and service.

Awards & Recognitions 🏅

Dr. Wall’s exemplary service has earned him numerous military and civilian accolades. These include the Bronze Star Medal, NATO Medal, Afghanistan Campaign Medal, Global War on Terrorism Service Medal, and the Honorable Order of Saint Martin. He’s received multiple Army Commendation and Achievement Medals, along with California-specific honors like the California Medal of Merit and Drill Attendance Ribbon with multiple stars. Notably, he was recognized as “Citizen Warrior of the Month” by California ARNG Magazine in August 2018. Dr. Wall has also been honored with plaques and certificates from NATO, Bulgarian Joint Forces, and various military medical programs. His academic achievements include tenure at Loma Linda University and leadership roles in key training inspections. These honors reflect his unwavering commitment to excellence, leadership in medical readiness, and profound impact in both academic and military sectors.

Research Interests 🔬

Dr. Wall’s research focuses on cancer biology, with specific expertise in molecular mechanisms of disease, targeted therapies, and translational oncology. His work bridges basic science and clinical application, especially in the context of proton therapy and health disparities in underserved populations. At Loma Linda University, he leads interdisciplinary teams addressing tumor microenvironments, cancer signaling pathways, and innovative therapeutics. Dr. Wall also contributes to Department of Defense research as a peer reviewer, ensuring scientific rigor in funded medical studies. His research often integrates his military background, exploring how stress and trauma-related factors influence cancer biology and immune responses. As Director of R&D at a leading proton treatment center, he’s advancing precision medicine in oncology. Dr. Wall’s work is marked by its practical implications, scientific depth, and commitment to improving patient care—particularly for populations affected by health inequities or involved in military service.

Publications

  • Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines

    International Journal of Molecular Sciences
    2025-03-19 | Journal article
    DOI: 10.3390/ijms26062766
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Ryan N. Fuller; Antonella Bertucci; Amy Nguyen; Quanqing Zhang; Tobias Emge; Kristopher E. Boyle; Nathan R. Wall; Marcelo Vazquez

  • A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs

    Cancers
    2024-09-27 | Journal article
    DOI: 10.3390/cancers16193293
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Joab Galvan Bustillos; Ryan N. Fuller; David Caba Molina; Antonella Bertucci; Kristopher E. Boyle; Marcelo E. Vazquez; Nathan R. Wal

  • A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

    Vaccines
    2023-12-18 | Journal article
    DOI: 10.3390/vaccines11121865
    CONTRIBUTORS: Béla Dénes; Ryan Fuller; Wayne Kelin; Tessa Levin; Jaipuneet Gil; Aaren Harewood; Márta Lőrincz; Nathan Wall; Anthony Firek; William Langridg

Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

Published on by Cognitive Scientist Awards

Mr. Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

PhD Scholar at Acharya and BM Reddy College of Pharmacy, Bengaluru, India

Mr. Rohit Pal is a dedicated and emerging researcher in the field of pharmaceutical sciences, particularly focusing on drug discovery and development. Currently pursuing his Ph.D. at Acharya & BM Reddy College of Pharmacy in Bengaluru, he is engaged in innovative research on Pyrimidine derivatives as fourth-generation EGFR inhibitors to combat Non-Small Cell Lung Cancer (NSCLC). With a strong academic background, including an M.Pharmacy in Pharmaceutical Chemistry, Mr. Pal combines his expertise in chemical synthesis with cutting-edge computational techniques like molecular docking and structure-activity relationship (SAR) analysis. His work spans multiple research areas, including anticonvulsant activity, anti-inflammatory research, and the pharmacognostic standardization of endangered species like Passiflora vitifolia. Throughout his career, Mr. Pal has demonstrated a capacity for both in-silico drug design and experimental testing, balancing theoretical approaches with hands-on experimentation. His impressive publication record in respected journals further showcases his capability to contribute to the scientific community. As a promising young researcher, Mr. Pal’s ongoing work not only advances pharmaceutical sciences but also holds potential for meaningful clinical applications in cancer therapy and drug design.

Profile

Orcid

 

Education 🎓

Mr. Rohit Pal’s educational background demonstrates a consistent pursuit of excellence in the field of pharmaceutical sciences. He is currently enrolled in a Ph.D. program at Acharya & BM Reddy College of Pharmacy in Bengaluru, Karnataka, where his research is focused on the development of Pyrimidine derivatives as EGFR inhibitors to target Non-Small Cell Lung Cancer (NSCLC). Prior to his doctoral studies, Mr. Pal completed his M.Pharmacy in Pharmaceutical Chemistry from ISF College of Pharmacy in Moga, Punjab, achieving a notable CGPA of 9.07. His academic journey began with a B. Pharmacy from Dev Bhoomi Institute of Pharmacy and Research, Dehradun, where he gained a robust foundation in pharmaceutical sciences. Additionally, Mr. Pal holds a D. Pharmacy from SGGS College of Pharmacy, Chandigarh, further demonstrating his dedication to the field from the onset of his academic career. His varied educational experiences have shaped his interdisciplinary approach to pharmaceutical research, combining knowledge from chemistry, biology, and computational sciences. This solid academic foundation has propelled Mr. Pal to explore complex drug development challenges, particularly in cancer therapy, with a keen interest in molecular-level drug interactions.

Work Experience 💼

Mr. Rohit Pal’s professional experience reflects a promising trajectory in pharmaceutical research and drug discovery. As a Ph.D. scholar at Acharya & BM Reddy College of Pharmacy, he is deeply involved in researching Pyrimidine derivatives for EGFR inhibition in Non-Small Cell Lung Cancer (NSCLC). His research explores the design, synthesis, and evaluation of novel drug candidates, combining in-vitro testing with computational drug design. Through the use of molecular docking and structure-activity relationship (SAR) analysis, Mr. Pal aims to identify compounds with high therapeutic potential. Beyond his Ph.D. work, Mr. Pal has worked on various other research projects, including 1,2,4-triazine derivatives for anticonvulsant activity and the anti-inflammatory properties of Passiflora vitifolia, an endangered plant species. His work spans both synthetic chemistry and biological testing, allowing him to gain expertise in pharmacological assays and computational modeling. Mr. Pal’s professional experience also includes using sophisticated instruments such as HPLC, UV spectrophotometers, and Microwave Synthesizers, which complement his experimental work and ensure the reliability of his results. These experiences have positioned him well for future leadership roles in pharmaceutical research and drug developmen

Awards and Honors

Although still in the early stages of his academic career, Mr. Rohit Pal has already garnered significant recognition for his research efforts. His academic excellence is reflected in his M.Pharmacy CGPA of 9.07, placing him among the top students in his cohort. Mr. Pal’s research has been published in reputable journals such as the Journal of Biomolecular Structure and Dynamics and Chemical Physics Impact, demonstrating the impact and quality of his work. These publications are indicative of his ability to produce research that contributes to the scientific community. Despite being early in his career, his involvement in cutting-edge research on Pyrimidine derivatives and EGFR inhibitors has already gained attention within the academic and pharmaceutical fields. His dedication to molecular docking, drug design, and pharmacognostic studies positions him for further recognition. As Mr. Pal continues to contribute to innovative drug development solutions, he is likely to receive more prestigious awards and honors, reflecting the growing importance of his work in cancer research and pharmaceutical chemistry.

Research Interests

Mr. Rohit Pal’s research interests are centered around the intersection of pharmaceutical chemistry and drug discovery. His primary focus is on developing Pyrimidine derivatives as fourth-generation EGFR inhibitors aimed at Non-Small Cell Lung Cancer (NSCLC), a serious health concern with limited therapeutic options. By targeting the epidermal growth factor receptor (EGFR), his work could offer more effective treatment alternatives for cancer patients. In addition to cancer research, Mr. Pal has explored 1,2,4-triazine derivatives for evaluating anticonvulsant activity, contributing to neurological disorder treatments. He is also interested in anti-inflammatory research, with a particular focus on Passiflora vitifolia, an endangered plant species, aiming to standardize its pharmacognostic properties. His multidisciplinary approach extends to the application of computational drug design, where he utilizes molecular docking and molecular dynamics simulations to predict drug-receptor interactions. Mr. Pal is committed to advancing drug development by combining experimental chemistry with in-silico methodologies, offering innovative solutions for complex healthcare challenges. His work on drug repurposing, targeted therapies, and sustainable drug sourcing reflects his holistic approach to addressing both scientific and global health concerns.

Research Skills

Mr. Rohit Pal possesses a wide range of research skills essential for successful pharmaceutical research. His proficiency in chemical synthesis includes techniques such as recrystallization, sublimation, and flash chromatography, which he applies to purify and isolate new compounds for testing. In addition to these laboratory techniques, Mr. Pal is highly skilled in analytical methods, including HPLC and UV spectrophotometry, to assess the purity and chemical composition of compounds. He is also adept at utilizing computational tools for drug design, particularly AutoDock, Biovia Drug Discovery Studio, and Pymol, to perform molecular docking and molecular dynamics simulations. These tools allow him to predict the interactions between drug candidates and their targets, enhancing the efficiency of drug development. Furthermore, Mr. Pal has experience in in-vitro biological testing, including assays for anticonvulsant, anti-inflammatory, and antioxidant activities, ensuring the biological relevance of his synthesized compounds. His ability to combine experimental techniques with computational modeling equips him to approach drug discovery from both theoretical and practical angles, ensuring well-rounded and impactful research outcomes.

📚 Publications

  • Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2024.141227
    • Date: April 2025
    • Contributors: Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Ghanshyam Teli; Viney Chawla; Pooja A. Chawla
  • Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.117034
    • Date: January 2025
    • Contributors: Ebna Azizal Omar; Rajesh R.; Pronoy Kanti Das; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Lalmohan Maji
  • Benzothiazole a privileged scaffold for cutting-edge anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.116831
    • Date: December 2024
    • Contributors: Aayishamma I; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Abhishek Ghara; Nimmagadda Venkata Satya Sai Aishwarya; Kumaraswamy B; Ketan R. Hosamani; Manjushree B V; Haripriya E
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
    • Journal: Journal of Biomolecular Structure and Dynamics
    • DOI: 10.1080/07391102.2023.2252082
    • Date: December 11, 2024
    • Contributors: Rohit Pal; Ghanshyam Teli; Sindhuja Sengupta; Lalmohan Maji; Gurubasavaraja Swamy Purawarga Matada
  • Exploring the anticancer potential of triazine derivatives: An outlook of designing strategies, docking studies, and structure-activity relationships (SAR)
    • Journal: ChemistrySelect
    • DOI: 10.1002/slct.202402766
    • Date: November 2024
    • Contributors: B. V. Manjushree; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Md. Ashadul Sk; M. P. Viji; Nimmagadda Venkata Satya Sai Aishwarya; Pronoy Kanti Das; I. Aayishamma; S. Mounika
  • Pyrazole, pyrazoline, and fused pyrazole derivatives: New horizons in EGFR-targeted anticancer agents
    • Journal: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202400880
    • Date: November 2024
    • Contributors: Ketan R Hosamani; Hemalatha K; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Kumaraswamy B; Aayishamma I; Nimmagadda Venkata Satya Sai Aishwarya

Conclusion 

Mr. Rohit Pal is an exceptionally talented and promising researcher in the field of pharmaceutical sciences. His research, focused on Pyrimidine derivatives as EGFR inhibitors for Non-Small Cell Lung Cancer (NSCLC), is not only innovative but holds significant promise for advancing cancer treatment. His combination of chemical synthesis, computational drug design, and biological testing reflects his multidisciplinary approach to pharmaceutical research. Mr. Pal’s commitment to anti-inflammatory, anticonvulsant, and pharmacognostic standardization further demonstrates his versatility as a researcher. While still in the early stages of his career, his publication record and expertise in molecular docking and drug design suggest that he is well on his way to becoming a leader in pharmaceutical research. His ongoing work could contribute to groundbreaking advancements in cancer therapy, neurological disorder treatments, and sustainable drug sourcing. With his strong educational background, solid professional experience, and growing body of work, Mr. Rohit Pal is undoubtedly a candidate with the potential to make meaningful contributions to drug development and global health. His future in research looks bright, and he is well-positioned for recognition in upcoming awards such as the Young Scientist Award.